Delivery Order SPE2DB24D2010-SPE2DB24FZTC1
- Not listed
- The U.S. Defense Logistics Agency (DLA) awarded Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical company Amerisourcebergen Corporation, a firm fixed price delivery order contract valued at $1,795.74 for the supply of 100 capsules of the drug Vyvanse 30 mg. The contract has a completion date of February 13, 2024. Amerisourcebergen Drug Corp serves as the prime contractor on this delivery order, which is part of a larger indefinite delivery contract (IDC) awarded by DLA...
- The U.S. Defense Logistics Agency (DLA) awarded Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a firm fixed-price delivery order contract worth $3,817.72 for 4,563,962,745 units of the pharmaceutical product Vyvanse 10 mg capsules. The contract has a period of performance through March 14, 2024. Amerisourcebergen Drug Corp is the prime contractor and there is no set-aside designation for this award. This delivery order is likely part of a larger indefinite delivery...
- The Defense Logistics Agency (DLA) Troop Support Medical awarded a $1,507.97 firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 100 units of the 60 mg dosage of the prescription drug Vyvanse. This delivery order has a completion date of February 8, 2024. Amerisourcebergen Drug Corp is the prime contractor on a larger indefinite delivery contract (IDC) with DLA, valued at up to $999,999,999.00 through December 31,...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of 30 mg Vyvanse capsules. The $1,718.34 contract has a completion date of February 8, 2024. Amerisourcebergen Drug Corp is the prime contractor on an indefinite delivery contract (IDC) with DLA, valued at up to $999,999,999.00 through December 2025, which serves as the primary vehicle for the company...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract valued at $3,671.23 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a global pharmaceutical distribution company. The contract is for the delivery of 10 mg Vyvanse capsules, a prescription medication, to support military treatment programs and facilities. The contract has a completion date of February 21, 2024. Amerisourcebergen Drug Corp serves as the...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of $8,920.04 worth of Vyvanse 10 mg capsules. The contract has a completion date of January 29, 2024 and was awarded on January 26, 2024. Amerisourcebergen Drug Corp is the prime contractor on a $999,999,999.00 indefinite delivery contract (IDC) with DLA to provide pharmaceutical products and medical supplies to DLA...
- This firm fixed price delivery order was awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of global pharmaceutical distributor Amerisourcebergen Corporation. The $22,000.27 contract is for the supply of Vyvanse 30mg capsules, with a completion date of March 5, 2024. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with DLA Troop Support Medical valued at up to $999,999,999.00 through December 2025, which...
- The U.S. Department of Defense's Defense Logistics Agency (DLA) Troop Support Medical has awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4,563,755,975 units of Vyvanse 30 mg capsules. The $2,094.24 contract has a completion date of February 23, 2024. Amerisourcebergen Drug Corp, a for-profit organization, serves as the prime contractor and has an indefinite delivery contract (IDC) with DLA with a potential value...
- The U.S. Defense Logistics Agency (DLA) has awarded a firm-fixed-price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, a leading global pharmaceutical sourcing and distribution company. The contract, valued at $6,166.40, is for the delivery of 20 mg capsules of the drug VYVANSE. This delivery order is part of a larger indefinite delivery contract (IDC) with a potential value of $999,999,999.00 awarded to AmerisourceBergen Drug Corp by DLA,...
- The Defense Logistics Agency (DLA) awarded Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a firm fixed price delivery order contract valued at $1,195.61 for the supply of Vyvanse 60 mg capsules. This order falls under a larger DLA Troop Support Medical indefinite delivery contract (IDC) valued at up to $999,999,999.00, which serves as the primary vehicle for Amerisourcebergen to provide pharmaceuticals and medical supplies to support the Department of Defense. No...
- SPE2DB24D2010Indefinite Delivery Contract
- SPE2DB24D2010-SPE2DB24FZTC1Delivery Order
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $1,439.14 to Amerisourcebergen Drug Corp, a subsidiary of the for-profit company Amerisourcebergen Corporation. This order is for the pharmaceutical product Vyvanse 50 mg capsules, with a completion date of April 4, 2024. Amerisourcebergen Drug Corp is the prime contractor on this delivery order, which is part of a larger indefinite delivery contract (IDC) with DLA valued at up to $999,999,999.00 through December 31, 2025. This IDC serves as the primary vehicle for Amerisourcebergen to provide a comprehensive range of pharmaceuticals and medical supplies to DLA Troop Support Medical facilities supporting the Department of Defense. No set-aside designation was used for this award.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.4k | 4/3/24 |